Back to

Arkansas

Biologics Compliance Guide for Clinics in Arkansas

Up-to-date information on protocols, safety, and regulations to help you deliver advanced patient care.

1. Summary

Arkansas medical providers interested in offering biologics and stem cell therapies must navigate both federal and state regulations to ensure full compliance. This guide offers a comprehensive overview of the requirements, including FDA and Arkansas state-specific rules, provider qualifications, and patient consent protocols, to help providers establish compliant biologic therapies in Arkansas.

2. FDA Compliance

The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps) under its HCT/P regulatory framework. Providers must ensure that any biologics used meet FDA criteria under the 21 CFR Part 1271 guidelines, including screening, testing, processing, and labeling. Certain exemptions may apply if the product meets criteria for “minimal manipulation” and “homologous use.” Clinics should confirm that their biologic products align with FDA standards to ensure compliance.

3. Arkansas State Regulations

In Arkansas, clinics must comply with the state’s health department regulations when offering biologics and stem cell treatments. Detailed guidance for Arkansas is available on the Arkansas Department of Health website. While Arkansas follows federal standards, state-specific guidelines may apply, especially around practitioner credentials and patient consent. Understanding and adhering to these state guidelines is key to accessible compliance and establishing a legal framework for biologic services in Arkansas.

4. Provider Qualifications

Only licensed physicians and appropriately credentialed healthcare practitioners are permitted to administer stem cell therapies in Arkansas. Medical doctors, osteopathic physicians, and other licensed providers with advanced training are generally authorized. Arkansas requires MD/DO licensure to administer human tissue products. Requirements may include completion of specific training related to regenerative medicine and biologics. Practitioners are encouraged to verify their eligibility through the Arkansas Medical Board to ensure they meet state qualifications.

5. Patient Informed Consent

Before treatment, patients must be provided with comprehensive information, including potential risks, benefits, and the experimental status of certain biologic treatments. Arkansas clinics should develop a detailed informed consent form that covers:

• A description of the procedure and its purpose
• Potential risks and benefits
• Alternative treatment options
• Disclaimers noting the experimental nature of some therapies

This consent process helps ensure that patients are fully informed and supports compliance with both state and federal standards.

6. Additional Requirements

Establish clear protocols for pre-treatment and post-treatment care to ensure patient safety and treatment effectiveness. These protocols should be based on clinical guidelines and updated regularly.

Develop and follow SOPs that cover handling, storage, and processing of biologics to maintain compliance with state and federal requirements. Written SOPs should be available for review by regulatory bodies.

Arkansas clinics offering biologic therapies should secure appropriate medical liability insurance to cover risks associated with these treatments. Consulting with an insurance provider experienced in medical and regenerative medicine liability coverage is recommended.

Marketing of biologic and stem cell therapies must be truthful and not misleading. Avoid unverified claims about the efficacy of treatments, as federal and state regulations restrict advertising that promises outcomes unsupported by clinical evidence. Refer to the FDA's guidelines on medical advertising for more information.

This guide is provided as an informational resource to help clinics and practitioners understand general compliance requirements for biologics in Arkansas. It is not intended to serve as legal advice or replace consultation with qualified legal professionals. Regulations may vary and are subject to change; clinics and practitioners should consult legal counsel or regulatory experts for advice specific to their circumstances and ensure full compliance with all applicable federal and state laws. The authors and publishers of this guide disclaim any liability arising from its use or reliance on the information provided.